Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma.
Mustafa N, Nee AHF, Chooi JY, Toh SHM, Chung TH, Selvarajan V, Fan S, Ng SB, Poon M, Chan E, Lee J, Chee YL, Jeyasekharan AD, Zhou L, Yang J, Chng WJ.
Mustafa N, et al. Among authors: ng sb.
J Immunother Cancer. 2021 Jul;9(7):e002123. doi: 10.1136/jitc-2020-002123.
J Immunother Cancer. 2021.
PMID: 34215687
Free PMC article.